Building first-in-class therapeutics that target disease-modifying pathways in neurodegeneration.
Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
Building first-in-class therapeutics that target disease-modifying pathways in neurodegeneration.
This company has no org chart yet
This company has no teams yet
This company has no offices yet
